In incipient AD stages III/IV (before the frontal cortex starts to form NFTs), we observed about 58% reduction in HSF1 protein and slightly increased p-eIF2α without PERK activation (Fig 1E and 1F). This evidence concerns the gene EIF2A and Alzheimer disease.